PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 153 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $66,000 | -25.8% | 17,400 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $89,000 | +1.1% | 17,400 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $88,000 | -17.8% | 17,400 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $107,000 | +32.1% | 17,400 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $81,000 | +11.0% | 17,400 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $73,000 | -33.0% | 17,400 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $109,000 | -22.1% | 17,400 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $140,000 | +7.7% | 17,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $130,000 | -9.1% | 17,400 | -27.5% | 0.00% | 0.0% |
| Q4 2017 | $143,000 | -19.2% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $177,000 | +8.6% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $163,000 | -28.2% | 24,000 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $227,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |